Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Accelerated Hypertension
Accelerated hypertension (malignant hypertension) is the term used to describe severe hypertension (180mmHg systolic and 110mmHg diastolic) occurring with retinopathy of Grade III (flame haemorrhages, dot and blot haemorrhages, hard and soft exudates) to Grade IV (papilloedema).1
The finding of accelerated hypertension in a patient demands urgent referral for assessment and treatment in order to minimise end-organ damage and reduce the risk of life threatening events such as myocardial infarction, encephalopathy, and intracerebral or subarachnoid haemorrhage.
Accelerated hypertension may be seen in association with renal disease or may occur as a discrete entity and will occur in approximately 1% of patients with essential hypertension. Average age at presentation is 40 years; men are more commonly affected than women.
Risk Factors
- Cigarette smoking
- Black ethnic origin
- Secondary hypertension sufferers
Accelerated hypertension may occur due to raised renin levels e.g. those found in association with2:
- Unilateral renovascular hypertension
- Renin-secreting neoplasms
- Trauma to the kidneys
- Renal vasculitis e.g. scleroderma, polyarteritis, and SLE
- Pheochromocytoma
- Cocaine abuse
- Clonidine withdrawal
- Sodium-volume overload and low renin levels e.g. acute glomerulonephritis, primary aldosteronism
- Pre-eclampsia/eclampsia
This may be asymptomatic, or may present with any of the many symptoms and/or signs of end organ damage:
- Headache
- Fits
- Nausea and vomiting
- Visual disturbance
- Chest pain
- Neurological deficit e.g. CVA
- Bleeding due to disseminated intravascular coagulopathy (DIC)
- Microangiopathic haemolytic anaemia
The investigation of any patient thought to have accelerated hypertension should be undertaken urgently and by doctors with expertise in this field. Investigations should include1:
- Full history; including
- Past medical history
- Full systems review
- Drug history including over the counter, herbal remedies and recreational drugs
- Full examination; including
- Blood pressure measurements lying, standing and in both arms
- Fundoscopy
- Neurological examination
- ± Ambulatory blood pressure monitoring
- Urine dip testing for protein and blood
- U &E's
- Blood sugar measurement
- Fasting blood lipids
- ECG
- ±CT/MRI scan of head or kidneys
- ±Plasma renin activity
- ±Plasma aldosterone level
- ±Catecholamine levels
- FBC ± Clotting screen
- ±Creatinine clearance
- ±Auto-antibody levels e.g. anti-nuclear factor
Management of Accelerated Hypertension
- Patients may be admitted to hospital.
- Patients typically have altered blood pressure autoregulation; reducing the blood pressure too fast may result in organ hypoperfusion.
- The initial goal is to reduce the mean arterial pressure by approximately 25% over the first 24-48 hours.
- An arterial line is helpful for continuous titration of blood pressure.
- Sodium and volume depletion may be severe, and volume expansion with isotonic sodium chloride solution must be considered.
General Management
All patients with hypertension should be given advice on lifestyle measures which will help to reduce their overall risk of cardiovascular disease. Such measures include1:
- Maintaining a body mass index of 20-25 kg/m2
- Reduce salt intake to <100 mmol/day
- Limit alcohol consumption to < 3 units per day for men and 2 units per day for women.
- Regular exercise (at least 30 minutes per day for at least 3 days a week)
- Eat at least 5 portions a day of fresh fruit and vegetables
- Reduce amounts of fat eaten, particularly animal fats
Drug treatment
Many patients will require more than one agent to achieve an acceptable in blood pressure. In severe hypertension it is thought safer to add drugs in a step wise manner until adequate control is achieved, and later stepped down if the fall in blood pressure is greater than desirable.
| Drug Management of Hypertension 3 | ||
|---|---|---|
| Younger (<55 years) and non black | Older ( >55 years) or black | |
| STEP 1 | A | C (or D) |
| STEP 2 | A + C (or D) | A + C (or D) |
| STEP 3 | A + C + D | A + C + D |
| STEP 4 | Consider adding:
|
Consider adding:
|
A: ACE inhibitor or angiotensin receptor blocker, C: Calcium channel blocker, D: Diuretic (thiazide and thiazide-like)
Beta-blockers are no longer preferred therapy for hypertension.3 However, they may be considered in young people who:
- Have intolerance to ACE inhibitors or angiotensin 2 receptor antagonists
- Are women of child-bearing age
- Show evidence of increased sympathetic drive
If hypertension is uncontrolled with a combination of 4 drugs, seek specialist advice.
Additional drug therapies
The use of a statin should be considered in patients below the age of 80, with raised cholesterol levels or with a 10 year risk of cardiovascular disease > 20%.4The use of aspirin 75mg may be considered once the blood pressure is controlled to levels of <150/90 in patients over the age of 55 with end organ damage, diabetes or a 10 year risk of cardiovascular disease greater than 20%.
Without treatment accelerated hypertension may result in death within a year in over 90% of patients as a result of end organ damage e.g. MI, CVA or renal failure. The prognosis has improved dramatically over the last few decades, and with optimal treatment the 5 year survival rate is > 80%.
Document References
- Williams B, Poulter NR, Brown MJ, et al; British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.; BMJ. 2004 Mar 13;328(7440):634-40.
- Blumenfeld JD, Laragh JH; Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens. 2001 Nov;14(11 Pt 1):1154-67. [abstract]
- Hypertension - management of hypertension in adults in primary care, NICE (2006)
- No authors listed; JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.; Heart. 2005 Dec;91 Suppl 5:v1-52.
Internet and Further Reading
- Bisognano JD, Orsini AN; Hypertension, Malignant. e-Medicine; October 2006
DocID: 1746
Document Version: 20
DocRef: bgp569
Last Updated: 9 Apr 2007
Review Date: 8 Apr 2009
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicineOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
*** NEW *** Patient UK Newspaper
View current health newsMedical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)

Want to search some more? Use the Google Search box below to search our site.

Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
